Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacological Studies of SSS11 in Patients With Gout and Hyperuricemia After Multiple Administrations, Dose Escalation, Randomized Double-blind, Placebo-controlled Trials
Latest Information Update: 11 Oct 2024
At a glance
- Drugs Pegadricase (Primary)
- Indications Gout
- Focus Adverse reactions
- 11 Oct 2024 New trial record